Weill Cornell Medicine, 1300 York Ave, New York, NY, 10065, USA.
Mbarara University of Science and Technology, Mbarara, Uganda.
Trials. 2024 Jul 1;25(1):430. doi: 10.1186/s13063-024-08286-4.
BACKGROUND: Rural African people living with HIV face significant challenges in entering and remaining in HIV care. In rural Uganda, for example, there is a threefold higher prevalence of HIV compared to the national average and lower engagement throughout the HIV continuum of care. There is an urgent need for appropriate interventions to improve entry and retention in HIV care for rural Ugandans with HIV. Though many adults living with HIV in rural areas prioritize seeking care services from traditional healers over formal clinical services, healers have not been integrated into HIV care programs. The Omuyambi trial is investigating the effectiveness of psychosocial support delivered by traditional healers as an adjunct to standard HIV care versus standard clinic-based HIV care alone. Additionally, we are evaluating the implementation process and outcomes, following the Consolidated Framework for Implementation Research. METHODS: This cluster randomized hybrid type 1 effectiveness-implementation trial will be conducted among 44 traditional healers in two districts of southwestern Uganda. Healers were randomized 1:1 into study arms, where healers in the intervention arm will provide 12 months of psychosocial support to adults with unsuppressed HIV viral loads receiving care at their practices. A total of 650 adults with unsuppressed HIV viral loads will be recruited from healer clusters in the Mbarara and Rwampara districts. The primary study outcome is HIV viral load measured at 12 months after enrollment, which will be analyzed by intention-to-treat. Secondary clinical outcome measures include (re)initiation of HIV care, antiretroviral therapy adherence, and retention in care. The implementation outcomes of adoption, fidelity, appropriateness, and acceptability will be evaluated through key informant interviews and structured surveys at baseline, 3, 9, 12, and 24 months. Sustainability will be measured through HIV viral load measurements at 24 months following enrollment. DISCUSSION: The Omuyambi trial is evaluating an approach that could improve HIV outcomes by incorporating previously overlooked community lay supporters into the HIV cascade of care. These findings could provide effectiveness and implementation evidence to guide the development of policies and programs aimed at improving HIV outcomes in rural Uganda and other countries where healers play an essential role in community health. TRIAL REGISTRATION: ClinicalTrials.gov NCT05943548. Registered on July 5, 2023. The current protocol version is 4.0 (September 29, 2023).
背景:生活在非洲农村的艾滋病毒感染者在进入和维持艾滋病毒护理方面面临重大挑战。例如,在乌干达农村,艾滋病毒的流行率是全国平均水平的三倍,艾滋病毒护理的各个连续环节的参与度都较低。迫切需要采取适当的干预措施,以提高乌干达农村艾滋病毒感染者进入和维持艾滋病毒护理的比例。尽管许多农村地区的成年艾滋病毒感染者更愿意优先向传统治疗师寻求护理服务,而不是正规临床服务,但治疗师并未被纳入艾滋病毒护理方案。Omuyambi 试验正在研究传统治疗师提供的心理社会支持作为标准艾滋病毒护理的辅助手段的有效性,与仅接受标准临床艾滋病毒护理相比。此外,我们正在根据综合实施研究框架评估实施过程和结果。
方法:这项在乌干达西南部两个地区的 44 名传统治疗师中进行的集群随机混合 1 型有效性实施试验,将传统治疗师随机分为两组,干预组的治疗师将在 12 个月内向在其诊所接受治疗且病毒载量未得到抑制的艾滋病毒感染者提供心理社会支持。总共将从 Mbarara 和 Rwampara 地区的治疗师群体中招募 650 名病毒载量未得到抑制的艾滋病毒感染者。主要研究结果是在招募后 12 个月测量的艾滋病毒病毒载量,将按意向治疗进行分析。次要临床结局指标包括(重新)开始艾滋病毒护理、抗逆转录病毒治疗依从性和护理保留率。采用关键知情人访谈和基线、3、9、12 和 24 个月的结构化调查评估采用、保真度、适宜性和可接受性等实施结果。通过在招募后 24 个月测量艾滋病毒病毒载量评估可持续性。
讨论:Omuyambi 试验正在评估一种方法,通过将以前被忽视的社区一线支持者纳入艾滋病毒护理连续体,从而改善艾滋病毒结果。这些发现可以为改善乌干达农村和其他国家的艾滋病毒结果提供有效性和实施证据,这些国家的治疗师在社区卫生中发挥着重要作用。
试验注册:ClinicalTrials.gov NCT05943548。于 2023 年 7 月 5 日注册。当前方案版本为 4.0(2023 年 9 月 29 日)。
Cochrane Database Syst Rev. 2011-3-16
Cochrane Database Syst Rev. 2006-7-19
Cochrane Database Syst Rev. 2008-7-16
Cochrane Database Syst Rev. 2010-3-17
Cochrane Database Syst Rev. 2012-12-12
Implement Sci Commun. 2023-7-27
Curr HIV/AIDS Rep. 2022-6
BMC Health Serv Res. 2022-3-1
Lancet Glob Health. 2021-5